Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of mRNA 1850

Trial Profile

Phase I study of mRNA 1850

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 15 Jan 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs MRNA 1850 (Primary)
  • Indications Bacterial infections; Parasitic infections; Viral infections
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 15 Jan 2016 New trial record
    • 12 Jan 2016 According to Moderna Therapeutics media release, company is planning to initiate this trial in the first quarter of 2016 and the company has also filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for mRNA 1850.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top